Regulatory barriers often inhibit the timely delivery of cutting-edge cellular therapeutics to patients burdened with chronic diseases and disabilities. The Bipartisan Policy Center and Regenerative Medicine Foundation are trying to change this by recommending that Congress support a federally funded registry for regenerative cell therapies.
This registry would help share the outcomes of potentially curative therapies so that the general public, clinicians, and researchers are able to learn from shared data. This would help inform decision-making and ultimately help accelerate the development and delivery of safe and effective cures for patients in the United States.
Check out the full article here: